Research Frontiers Reports First Quarter 2023 Financial Results and Will Host a Conference Call at 4:30p.m. Today
04 Maggio 2023 - 10:01PM
Research Frontiers Inc. (Nasdaq: REFR) announced its financial
results for its first quarter 2023. Management will host a
conference call today at 4:30 p.m. Eastern Time to discuss its
financial and operating results as well as recent developments.
|
• |
Who: Joseph M.
Harary, President & CEO |
|
• |
Date/Time: May
4, 2023, 4:30 PM ET |
|
• |
Dial-in
Information:1-888-334-5785 |
|
• |
Replay:
Available on Friday, May 5, 2023 for 90 days at
https://smartglass-ir.com/ |
Key Comments:
1. |
Car models from Cadillac, Ferrari, McLaren and at least one other
Asian car manufacturer are expected to be introduced into serial
production in 2023 using Research Frontiers patented SPD-SmartGlass
technology in their panoramic glass roofs. |
2. |
The Company’s fee income from licensing activities for the three
months ended March 31, 2023 increased by 43% to $248,175 as
compared to $173,828 for the three months ended March 31, 2022.
Compared to the fourth quarter ending December 31, 2022, fee income
in the first quarter of 2023 increased by 91% from $129,904. This
increase in fee income was primarily the result of higher royalties
from the automotive and aircraft markets, both as compared to the
first quarter of 2022 as well as the most recently completed fourth
quarter of 2022. |
3. |
The Company expects revenue in all market segments to increase as
new car models, aircraft, trains and other products using the
Company’s SPD-SmartGlass technology are introduced into the
market. |
4. |
At March 31, 2023, the Company had cash and cash equivalents and
marketable securities of approximately $4.1 million, and working
capital of $4.6 million. The Company has no debt and expects to
have sufficient working capital for at least the next five years of
operations. |
For more details, please see the Company’s
Annual Report on Form 10-Q which was filed today with the SEC, the
contents of which are incorporated by reference herein.
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly
traded technology company and the developer of patented SPD-Smart
light-control film technology which allows users to instantly,
precisely and uniformly control the shading of glass or plastic
products, either manually or automatically. Research Frontiers has
licensed its smart glass technology to over 40 companies that
include well known chemical, material science and glass companies.
Products using Research Frontiers’ smart glass technology are being
used in tens of thousands of cars, aircraft, yachts, trains, homes,
offices, museums and other buildings. For more information, please
visit our website at www.SmartGlass.com, and on Facebook, Twitter,
LinkedIn and YouTube.
Note: From time to time Research Frontiers may
issue forward-looking statements which involve risks and
uncertainties. This press release contains forward-looking
statements. Actual results, especially those reliant on activities
by third parties, could differ and are not guaranteed. Any
forward-looking statements should be considered accordingly.
“SPD-Smart” and “SPD-SmartGlass” are trademarks of Research
Frontiers Inc. Celestiq is a trademark of General Motors.
CONTACT:Joseph M. HararyPresident and
CEOResearch Frontiers Inc.+1-516-364-1902Info@SmartGlass.com
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Balance Sheets
|
|
March 31, 2023(Unaudited) |
|
|
December 31, 2022 |
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,152,433 |
|
|
$ |
4,230,916 |
|
Marketable securities |
|
|
2,988,060 |
|
|
|
- |
|
Royalties receivable, net of reserves of $1,153,450 in 2023 and
$1,158,450 in 2022, respectively |
|
|
683,863 |
|
|
|
589,599 |
|
Prepaid expenses and other current assets |
|
|
93,188 |
|
|
|
100,973 |
|
Total current assets |
|
|
4,917,544 |
|
|
|
4,921,488 |
|
|
|
|
|
|
|
|
|
|
Fixed assets, net |
|
|
59,274 |
|
|
|
65,388 |
|
Operating lease ROU
assets |
|
|
286,551 |
|
|
|
323,509 |
|
Deposits and other assets |
|
|
56,066 |
|
|
|
56,066 |
|
Total assets |
|
$ |
5,319,435 |
|
|
$ |
5,366,451 |
|
|
|
|
|
|
|
|
|
|
Liabilities and Shareholders’ Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Current portion of operating lease liability |
|
$ |
199,672 |
|
|
$ |
196,405 |
|
Accounts payable |
|
|
25,440 |
|
|
|
71,079 |
|
Accrued expenses and other |
|
|
46,730 |
|
|
|
34,379 |
|
Deferred revenue |
|
|
11,921 |
|
|
|
- |
|
Total current liabilities |
|
|
283,763 |
|
|
|
301,863 |
|
|
|
|
|
|
|
|
|
|
Operating lease liability, net of current portion |
|
|
216,943 |
|
|
|
267,723 |
|
Total liabilities |
|
|
500,706 |
|
|
|
569,586 |
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity: |
|
|
|
|
|
|
|
|
Common stock, par value $0.0001 per share; authorized 100,000,000
shares, issued and outstanding 33,509,287 as of March 31, 2023
and 33,150,396 as of December 31, 2022 |
|
|
3,351 |
|
|
|
3,315 |
|
Additional paid-in capital |
|
|
127,634,493 |
|
|
|
127,150,027 |
|
Accumulated deficit |
|
|
(122,819,115 |
) |
|
|
(122,356,477 |
) |
Total shareholders’ equity |
|
|
4,818,729 |
|
|
|
4,796,865 |
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders’ equity |
|
$ |
5,319,435 |
|
|
$ |
5,366,451 |
|
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Statements of Operations(Unaudited)
|
|
Three months ended March 31, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Fee income |
|
$ |
248,175 |
|
|
$ |
173,828 |
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
|
587,799 |
|
|
|
600,698 |
|
Research and development |
|
|
149,222 |
|
|
|
148,825 |
|
Total expenses |
|
|
737,021 |
|
|
|
749,523 |
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(488,846 |
) |
|
|
(575,695 |
) |
|
|
|
|
|
|
|
|
|
Net investment income
(loss) |
|
|
26,208 |
|
|
|
(52,653 |
) |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(462,638 |
) |
|
$ |
(628,348 |
) |
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per
common share |
|
$ |
(0.01 |
) |
|
$ |
(0.02 |
) |
|
|
|
|
|
|
|
|
|
Weighted average number of
common shares outstanding |
|
|
33,286,648 |
|
|
|
31,650,396 |
|
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Statements of Shareholders’ Equity(Unaudited)
For the three months ended March 31, 2022 and
2023
|
|
Common Stock |
|
|
Additional Paid-in |
|
|
Accumulated |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Deficit |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2022 |
|
|
31,650,396 |
|
|
$ |
3,165 |
|
|
$ |
123,467,886 |
|
|
$ |
(119,687,128 |
) |
|
$ |
3,783,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(628,348 |
) |
|
|
(628,348 |
) |
Balance, March 31, 2022 |
|
|
31,650,396 |
|
|
|
3,165 |
|
|
|
123,467,886 |
|
|
|
(120,315,476 |
) |
|
|
3,155,575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2023 |
|
|
33,150,396 |
|
|
$ |
3,315 |
|
|
$ |
127,150,027 |
|
|
$ |
(122,356,477 |
) |
|
$ |
4,796,865 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of warrants |
|
|
358,891 |
|
|
|
36 |
|
|
|
484,466 |
|
|
|
- |
|
|
|
484,502 |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(462,638 |
) |
|
|
(462,638 |
) |
Balance, March 31, 2023 |
|
|
33,509,287 |
|
|
$ |
3,351 |
|
|
$ |
127,634,493 |
|
|
$ |
(122,819,115 |
) |
|
$ |
4,818,729 |
|
RESEARCH FRONTIERS INCORPORATEDCondensed
Consolidated Statements of Cash Flows(Unaudited)
|
|
For the three months ended March 31, |
|
|
|
2023 |
|
|
2022 |
|
Cash flows from operating
activities: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(462,638 |
) |
|
$ |
(628,348 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
6,816 |
|
|
|
7,180 |
|
Realized loss on marketable securities |
|
|
- |
|
|
|
60,143 |
|
Unrealized gain on marketable securities |
|
|
(22,900 |
) |
|
|
- |
|
ROU asset amortization |
|
|
36,958 |
|
|
|
36,351 |
|
Bad debt recovery |
|
|
(5,000 |
) |
|
|
- |
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
Royalty receivables |
|
|
(89,264 |
) |
|
|
78,086 |
|
Prepaid expenses and other assets |
|
|
7,785 |
|
|
|
6,358 |
|
Accounts payable and accrued expenses |
|
|
(33,288 |
) |
|
|
(25,045 |
) |
Deferred revenue |
|
|
11,921 |
|
|
|
10,756 |
|
Operating lease liability |
|
|
(47,513 |
) |
|
|
(43,435 |
) |
Net cash used in operating activities |
|
|
(597,123 |
) |
|
|
(497,954 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities: |
|
|
|
|
|
|
|
|
Purchases of fixed assets |
|
|
(702 |
) |
|
|
(605 |
) |
Purchases of marketable securities |
|
|
(2,965,160 |
) |
|
|
- |
|
Sales of marketable securities |
|
|
- |
|
|
|
2,694,968 |
|
Net cash (used in) provided by investing activities |
|
|
(2,965,862 |
) |
|
|
2,694,363 |
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities: |
|
|
|
|
|
|
|
|
Net proceeds from exercise of warrants |
|
|
484,502 |
|
|
|
- |
|
Net cash provided by financing activities |
|
|
484,502 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in
cash and cash equivalents |
|
|
(3,078,483 |
) |
|
|
2,196,409 |
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at
beginning of period |
|
|
4,230,916 |
|
|
|
269,964 |
|
Cash and cash equivalents at
end of period |
|
$ |
1,152,433 |
|
|
$ |
2,466,373 |
|
Grafico Azioni Research Frontiers (NASDAQ:REFR)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Research Frontiers (NASDAQ:REFR)
Storico
Da Nov 2023 a Nov 2024